“Big Data, Patents, and the Future of Medicine”

Nicholson Price
  • Law and Technology
  • Health Law
Cardozo Law Review
2016

“Regulating Secrecy”

Nicholson Price
  • Law and Technology
  • Health Law
Washington Law Review
2016

“Privacy and Accountability in Black-Box Medicine”

Nicholson Price
  • Law and Technology
  • Health Law
Michigan Telecommunications and Technology Law Review
2016

“The Need for a Privacy Standard for Medical Devices That Transmit Protected Health Information Used in the Precision Medicine Initiative for Diabetes and Other Diseases”

Nicholson Price
  • Law and Technology
  • Health Law
Journal of Diabetes Science and Technology
2016

“Innovation Policy Failures in the Manufacturing of Drugs”

Nicholson Price
  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Introduction to ‘Timing is Everything: Balancing Access and Uncertainty’ ”

Nicholson Price
  • Law and Technology
  • Health Law
FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies
2015

“Black-Box Medicine”

Nicholson Price
  • Law and Technology
  • Health Law
Harvard Journal of Law & Technology
2015

“Will Clinical Trial Data Disclosure Reduce Incentives to Develop New Uses of Drugs?”

Nicholson Price
  • Law and Technology
  • Health Law
Nature Biotechnology
2015

“Are Trade Secrets Delaying Biosimilars?”

Nicholson Price
  • Law and Technology
  • Health Law
Science
2015

“Describing Black-Box Medicine”

Nicholson Price
  • Law and Technology
  • Health Law
Boston University Journal of Science & Technology Law
2015

“Models of Consent to Return of Incidental Findings in Genomic Research”

Nicholson Price
  • Law and Technology
  • Health Law
Hastings Center Report
2014

“Making Do in Making Drugs: Innovation Policy and Pharmaceutical Manufacturing”

Nicholson Price
  • Law and Technology
  • Health Law
Boston College Law Review
2014

“Patent Trolling - Why Bio & Pharmaceuticals Are at Risk”

Nicholson Price
  • Law and Technology
  • Health Law
Stanford Technology Law Review
2014

“Generic Entry Jujitsu: Innovation and Quality in Drug Manufacturing”

Nicholson Price
  • Law and Technology
  • Health Law
IP Theory
2014

“Nudging the FDA”

Nicholson Price
  • Law and Technology
  • Health Law
The American Interest
2014

“Informed Consent for Return of Incidental Findings in Genomic Research”

Nicholson Price
  • Law and Technology
  • Health Law
Genetics in Medicine
2013

“Problems of Innovation-Deficient Pharmaceutical Manufacturing”

Nicholson Price
  • Law and Technology
  • Health Law
New England Journal of Medicine
2013

“Unblocked Future: Why Gene Patents Won’t Hinder Whole-Genome Sequencing and Personalized Medicine”

Nicholson Price
  • Law and Technology
  • Health Law
Cardozo Law Review
2012

“Large-Scale Experimental Studies Show Unexpected Amino Acid Effects on Protein Expression and Solubility in Vivo in E. coli”

Nicholson Price
  • Law and Technology
  • Health Law
Microbial Informatics and Experimentation
2011

“Am I My Son? Human Clones and the Modern Family”

Nicholson Price
  • Law and Technology
  • Health Law
Columbia Science and Technology Law Review
2010

“The Deepwater Horizon Oil Spill: Potential Insurance Coverage Implications”

Nicholson Price
  • Law and Technology
  • Health Law
Insurance Coverage Law Bulletin
2010

“Understanding the Physical Properties that Control Protein Crystallization by Analysis of Large-Sale Experimental Data”

Nicholson Price
  • Law and Technology
  • Health Law
Nature Biotechnology
2009

“Patenting Race: The Problems of Ethnic Genetic Testing Patents”

Nicholson Price
  • Law and Technology
  • Health Law
Columbia Science and Technology Law Review
2007

“MxA Gene Expression Analysis as an Interferon-beta Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity”

Nicholson Price
  • Law and Technology
  • Health Law
Molecular Diagnosis
2003